The Zepto® Precision Cataract Surgery System (Zepto PCS™) was developed for Mynosys by the Zepto Product Team. Zepto is a registered trademark of Mynosys Cellular Devices, Inc.
Tom Dunlap, President and CEO
Mr. Dunlap has over three decades of global experience leading and building Ophthalmic medical device companies. He has a proven track record of generating commercialization successes in both entrepreneurial ventures and multinational companies. Prior to his current position, Tom was an Independent Board Member at Mynosys Cellular Devices Inc., a Cooperation Partner at Life Sciences Consulting Network Ltd. and Principal & Founder of Dunlap Ophthalmology Consulting. Mr. Dunlap is a Former CEO at HOYA Surgical Optics and has held executive management positions at Allergan Medical Optics, Bausch + Lomb and American Hospital Supply Corporation. He has held previous Board roles at a number of early stage ophthalmic medical device companies. Tom is an Advisory Board member for the Asian and European Ophthalmology Futures Forums. He holds an MBA, Magna Cum Laude from the University of Southern California in Los Angeles, California and a BA, Cum Laude from Ashland University in Ashland, Ohio.
Taoufiq Jellal, Vice President EURMEA Sales and Marketing
Taoufiq Jellal (known as TJ) has been our Vice President Sales & Marketing for Europe, Middle East and Africa since August 2017. Mr. Jellal served as General Manager EUMEA at Transcend Medical and successfully contributed to the acquisition of Transcend by Novartis/Alcon. Prior to Transcend he served as Vice President of Sales for EUMEA at Optonol, Inc. Mr. Jellal has extensive sales and marketing experience in ophthalmology in Europe the Middle East and Africa, having started his career in ophthalmology in 1989. He has served in various leading sales and marketing positions in the ophthalmic field for almost 30 years. Mr. Jellal held the positions of International Sales Director at Second Sight; Business Unit Manager, Surgical, at Alcon Pharmaceuticals, and General Manager EMEA at TearScience and NeoVista. He has served in international positions in the following companies: Iridex Corporation, Heidelberg Engineering, Allergan and Storz. He has a Master degree in Sociology from the University of Paris, France and an MBA from the International Business School in Hamburg, Germany. Mr. Jellal is father of twin sons, an amateur golfer and a convinced epicurean.
Todd M. Pinkney, Vice President U.S. Sales and Marketing
Todd Pinkney has over 25 years of experience in Medical Devices, Biologics, and Pharmaceuticals across all aspects of commercialization including Sales, Marketing, Reimbursement and Managed Care. Mr. Pinkney’s current responsibilities consists of leading the U.S. Commercial launch of Zepto® Precision Pulse Capsulotomy, including developing and executing marketing, reimbursement, and sales plans to ensure the profit growth and expansion of the company’s products and services.
Mr. Pinkney joins Mynosys from Allergan where he managed all U.S. marketing efforts for Allergan’s Surgical and Therapeutics Glaucoma Franchise. During his career at Allergan, Mr. Pinkney led the U.S. commercial launch for the XEN® Surgical Treatment System and oversaw the professional marketing initiatives for Restasis®, Allergan’s flagship Dry Eye product. Prior to that he held various leadership roles at Genentech, Bristol-Myers Squibb and Merck. Mr. Pinkney holds an M.B.A. from Temple University and a B.S. degree from the University of Pittsburgh. When time permits, he enjoys spending time with family/friends and fulfilling his passion, educating others about marine conservation, as a volunteer Master Scuba Diver at the Aquarium of the Pacific.
Patrick Lydon, OD; Vice President, Clinical Affairs and Training
Dr. Lydon began his career in ophthalmology first as a private practice optometrist and later as Director of Doctor Relations with Pearle Vision Care. In this role his responsibilities included peer review, clinical quality assurance and business development. Subsequently, he assumed entrepreneurial leadership roles in Sales, Clinical Training and Marketing at Cole Managed Vision, Genentech, NeoVista, AcuFocus and Refocus. Pat joined Mynosys in 2016 and has been leading the commercial launch of Zepto. When time permits, Pat also plays guitar in two bands, scuba dives and attempts to golf.
Tom McGaffigan, VP Research and Development
Tom joined Mynosys, in 2013 as Vice President of Research and Development. He currently holds 52 US patents in areas including shape memory alloy connectors, self-regulating heaters, medical devices, optical products, and numerous other inventions.
Mr. McGaffigan studied Industrial and Mechanical Engineering at UC Berkeley and California State University, Chico. After finishing his Mechanical Engineering degree, he joined Raychem in the Electronics division. Tom led several R&D teams while at Raychem developing, among other things, Shape Memory Alloy Connectors for commercial and military use. In the startup arena, Tom was instrumental in the development of transurethral ablation devices and RF power consoles at VidaMed, as well as surgical seals and cut devices at Starion. Both companies were successfully acquired in planned buyouts.
Jim Conroy M.D., Clinical Training Specialist
Dr. Jim Conroy is a Board-Certified Family Practice physician and a Fellow of the American Academy of Family Practice, with certification in Sports Medicine. He has extensive administrative experience including years as Chief of Family Practice and Chief of Prevention at Santa Teresa Medical Center in San Jose, CA. Subsequently, his later career with Kaiser took him to North Carolina as Senior Lead, with operations management responsibility. Dr. Conroy retired from The Permanente Medical Group after 29 years prior to joining Mynosys. Dr. Conroy received two degrees from MIT and performed research work at the Massachusetts General Hospital, before enrolling at the University of Cincinnati Medical School.